We have developed a highly sensitive QRT-PCR method for the measurement of CYP11B1 (11␤-hydroxylase) and CYP11B2 (aldosterone synthase) mRNAs to study their expression in the rat brain in response to dietary sodium manipulation and angiotensin (Ang)II infusion. Male Wistar Kyoto rats (n ‫؍‬ 6) were fed normal, high, or low sodium diets for 12 d or were administered AngII or vehicle for 7 d. CYP11B2 and CYP11B1 expression was measured in RNA from adrenal gland and discrete brain regions using real-time QRT-PCR. Sodium restriction increased adrenal CYP11B2 expression 57-fold from 1.0 ؋ 10 5 ؎ 0.6 ؋ 10 5 to 57 ؋ 10 5 ؎ 22 ؋ 10 5 copies/g RNA (mean ؎ SEM; P < 0.05);in the hippocampus, 14-fold from 5.4 ؋ 10 2 ؎ 0.8 ؋ 10 2 to 74 ؋ 10 2 ؎ 31 ؋ 10 2 copies/g RNA (P < 0.05); and in the cerebellum, 5-fold from 1.9 ؋ 10 3 ؎ 0.7 ؋ 10 3 to 9.9 ؋ 10 3 ؎ 3.0 ؋ 10 3 copies/g RNA (P < 0.01). CYP11B2 gene expression in the brainstem and hypothalamus was not affected. High-sodium diet reduced adrenal CYP11B2 expression to 0.19 ؋ 10 5 ؎ 0.1 ؋ 10 5 copies/g RNA (P < 0.05) but did not affect central nervous system (CNS) expression significantly. AngII significantly increased adrenal CYP11B2 expression but did not affect CNS expression. Brain CYP11B1 mRNA levels were 10-to 1000-fold higher than CYP11B2 but were unaffected by dietary sodium or AngII. To summarize, we have identified a local CYP11B2 response to sodium depletion in the hippocampus and cerebellum. This is the first such regulation of CYP11B2 transcription to be identified in the CNS. (Endocrinology 144: 3321-3328, 2003)
A LDOSTERONE IS THE principal mineralocorticoid
and plays a key role in cardiovascular homoeostasis by influencing vascular tone and fluid and electrolyte balance (1) . Its synthesis from 11-deoxycorticosterone (DOC) in the zona glomerulosa of the adrenal cortex is catalyzed by aldosterone synthase, the product of the CYP11B2 gene. The principal glucocorticoid in rodents is corticosterone, synthesized from DOC in the adrenal zona fasciculata by the CYP11B1 gene product, 11␤-hydroxylase. Although the adrenal cortex is essential for survival and is the major source of both aldosterone and corticosterone, expression of the CYP11B1 and CYP11B2 genes has been identified at low levels in extraadrenal tissues including the heart and vasculature (2) (3) (4) (5) (6) (7) . Previous studies by ourselves and others have also identified the brain as a major extraadrenal site of CYP11B1 and CYP11B2 expression. Indeed, transcription of the complete range of genes required to convert cholesterol to aldosterone or corticosterone has been identified in the central nervous system (CNS) (8 -11) , and synthesis of corticosteroids by brain tissue has also been demonstrated (12, 13) . Our own studies have shown the cerebellum and hippocampus to contain enough aldosterone synthase and 11␤-hydroxylase to be detected by immunohistochemistry (9) .
Glucocorticoid receptors (GR) are expressed at high levels throughout the brain. Mineralocorticoid receptors (MR) are expressed at a high level only in the hippocampus, septum, and a few brainstem nuclei. The local synthesis of aldosterone and corticosterone at sites close to MR and GR may have profound pathophysiological consequences. For example, intracerebroventricular infusions of glucocorticoids and mineralocorticoids have major effects on systemic blood pressure, without significantly raising hormone concentrations in the systemic circulation (14) . Mineralocorticoids in the brain also influence fluid homeostasis through effects on thirst and salt appetite (15, 16) , and there is evidence that glucocorticoids can influence cognition and have neuroprotective or neurodegenerative properties under different circumstances via both MR and GR (17, 18) . In the adrenal cortex, the expression of the aldosterone synthase gene, CYP11B2, is mainly controlled by body sodium status via the renin-angiotensin system (RAS) (19) . The transcription of adrenal CYP11B2 is enhanced by sodium deficiency, angiotensin (Ang)II, and small increases in dietary potassium, but it is suppressed by long-term administration of high doses of ACTH. In contrast, CYP11B1 expression is determined by physiological variations of ACTH (20) . Whether extraadrenal steroid synthesis is similarly controlled and whether these steroids have the same actions on blood pressure and sodium acquisition as adrenally derived steroid is not known.
The elucidation of the control mechanisms controlling extraadrenal steroidogenesis is essential to assess the physiological and pathophysiological role of locally synthesized Abbreviations: Ang, Angiotensin; CNS, central nervous system; DOC, 11-deoxycorticosterone; GR, glucocorticoid receptor(s); 11␤-HSD2, 11␤-hydroxysteroid dehydrogenase type 2; MR, mineralocorticoid receptor(s); PRA, plasma renin activity; QRT-PCR, quantitative RT-PCR; RAS, renin-angiotensin system. hormones. However, the low levels of CYP11B1 and CYP11B2 transcripts present in nonadrenal tissue render them extremely difficult to quantify. To study the transcriptional regulation of these genes, we developed a method for the quantitative detection of CYP11B1 and CYP11B2 transcripts using the Roche LightCycler system in combination with homologous RNA standards. We used this method to quantify CYP11B2 mRNA levels in the rat adrenal gland and various regions of the rat CNS and also to identify significant changes in gene expression caused by known modulators of adrenal CYP11B2 transcription, dietary sodium, and AngII. Simultaneous measurement of CYP11B1 mRNA expression was also performed.
Materials and Methods

Experimental animals
We confirm that all animal experimentation described in this article was conducted in accord with accepted standards of humane animal care.
Effects of sodium depletion and high-sodium diet
Three groups of male Wistar Kyoto rats (n ϭ 6) were fed normal (0.3%), high (3%), or low (0.03%) sodium diets (Special Diet Services Ltd., Witham, Essex, UK) for 12 d. The animals were then killed by decapitation at 12-h intervals, and trunk blood was collected for assay of plasma steroid levels and plasma renin activity (PRA). The adrenal glands, hippocampus, cerebellum, hypothalamus, brainstem, and cerebral cortex were removed, cleaned, and frozen at Ϫ70 C.
Effect of AngII
Two groups of animals (n ϭ 6) were infused with normal saline vehicle or AngII (200 ng/kg⅐min) using Alzet osmotic minipump model 2002 (pump rate, 0.5 l/h) (Alzet Osmotic Minipumps, Cupertino, CA) for 7 d. Blood and tissues were collected as described above.
Plasma steroid and renin measurement
Plasma aldosterone was determined by RIA (Diagnostic Products Corp., Los Angeles, CA). Plasma corticosterone was analyzed by direct RIA in diluted, heat-deproteinized plasma. A highly specific rabbit anticorticosterone antiserum and 3 H-corticosterone were used. Bound radioactivity was measured with an antirabbit proximity scintillation reagent (Amersham Biosciences UK Ltd., Little Chalfont, Buckinghamshire, UK).
PRA was measured by a modified version of the method described by Morton and Wallace (21) . Aliquots of plasma were incubated at 0 and 37 C for 30 min with AngI antiserum in Tris buffer (pH 7.4; 50 mm). The AngI generated and trapped was measured by RIA.
Total RNA isolation
Tissues were homogenized using a RiboLyzer Cell Disruptor (Hybaid, Middlesex, UK), and total tissue RNA was isolated using RNABee (200 mg/ml; Biogenesis, Poole, UK). RNA was treated with DNase (DNA-free, Ambion, Inc., Austin, TX), and the RNA quality was confirmed by electrophoresis on agarose gels. RNA concentration was measured using the RiboGreen RNA quantitation kit (Molecular Probes, Inc., Leiden, The Netherlands) and a Wallac Victor 1420 Multilabel Counter (PerkinElmer Life Sciences, Boston, MA).
Real-time quantitative RT-PCR (QRT-PCR)
The RB1 primers were designed to amplify a 324-bp fragment corresponding to positions 552-875 of the CYP11B1 gene, whereas the RB2 primers were designed to amplify a 324-bp segment corresponding to positions 558 -881 of the CYP11B2 gene (Table 1 ) (22) . These primers are exon-spanning and therefore exclude contaminating genomic DNA. Primers were manufactured by MWG-Biotech (Ebersberg, Germany).
Synthesis of standards
Two exogenous homologous mRNA standards for CYP11B1 and CYP11B2 were prepared as follows. CYP11B1 or CYP11B2 cDNA was prepared from Wistar Kyoto rat adrenal RNA using the RB1 or RB2 primers and the GeneAmp Gold RNA PCR Core Kit (PE Applied Biosystems, Foster City, CA), following their standard protocol. The annealing temperature was 60 C, and the reaction was performed for 43 cycles. Products were subcloned into a pSP64poly(A) vector (Promega Corp., Madison, WI). The identity of the inserts was confirmed by sequencing. Plasmids were then linearized with PvuII, and mRNA templates were obtained by in vitro transcription using RiboMax Large Scale RNA Production Systems-SP6 (Promega Corp.). Transcript concentration was measured by UV absorbance (OD 260 ), and copy number was calculated by the formula: Transcript copy number/l ϭ [RNA concentration (g/l) ϫ 6.02 ϫ 10 23 ]/Transcript molecular weight.
Real time QRT-PCR
One-step real time QRT-PCR was performed using the LightCycler System (Roche Diagnostics, Mannheim, Germany) and the LightCycler RNA Master Hybridization Probes kit (Roche Diagnostics). Two pairs of gene sequence-specific hybridization probes homologous to exon 3 of rat CYP11B1 or CYP11B2 were designed and synthesized by TIB Molbiol (Berlin, Germany), each pair consisting of a fluorescein and LightCycler Red probe (Table 1) .
Tissue RNA (1 g) was used as a template for LightCycler amplification. One-microliter aliquots of sequential 10-fold mRNA standard dilutions were used to construct a standard curve. The LightCycler protocol was as follows: reverse transcription (61 C for 20 min), denaturation (95 C for 30 sec), amplification (95 C for 1 sec, annealing temperature for 15 sec, fluorescence measurement, 72 C for 14 sec), for up to 85 cycles or until all of the positive samples reached the plateau phase; and cooling (40 C for 30 sec). Sample copy number was extrapolated from the standard curve. Each sample was measured three times and its crossing point was used to calculate CYP11B1 or CYP11B2 copy number ( Fig. 1) . A negative control was included in each run. No crossing point greater than 42 cycles resulted from tissue RNA in this study, and most samples yielded crossing points in the range of 20 -35 cycles.
Each RNA sample was also subjected to PCR using the LightCyclerFastStart DNA Master Hybridization Probes kit (Roche Diagnostics) to confirm the absence of contaminating genomic DNA. The LightCycler protocol was as follows: denaturation (95 C for 10 min); amplification (95 C for 10 sec, annealing temperature for 10 sec, fluorescence measurement, 72 C for 5 sec), for up to 85 cycles or until all positive samples reached the plateau phase; and cooling (40 C for 30 sec).
The annealing temperatures were 52 C for CYP11B1 probes and 55 C for CYP11B2 probes.
The specificity of the CYP11B1 and CYP11B2 amplification was established by attempting to amplify the CYP11B1 standard with the RB2 primers and the CYP11B2 standard with the RB1 primers. No amplification was apparent in either case, demonstrating that the method is specific (data not shown).
Intra-and interassay variation
The LightCycler method uses fluorescent measurement to detect the point at which PCR enters the exponential phase of amplification. The fit point method was used to assess when samples entered this phase and to construct an optimized standard curve from the serial dilutions of homologous RNA standards (Fig. 1) . The intraassay precision of real-time QRT-PCR was assessed by performing 10 replicate CYP11B1 or CYP11B2 reactions in a single LightCycler run on adrenal or cerebral cortex total RNA. Interassay variation was assessed by CYP11B1 or CYP11B2 amplification of a single adrenal or cerebral cortex RNA sample over five separate LightCycler runs. The results of these are shown in Table 2 . These show that interassay variation is greater than intraassay variation and that the relative variation (coefficient of variance) is greater in samples that contain lower levels of CYP11B1 or CYP11B2 transcript. Also, whereas crossing point is extremely consistent in all tests, the extrapolated copy number is more variable, presumably because of small sample changes in the amplification of standard. Again, these differences are more pronounced at lower copy number, as would be expected. The higher variability at lower levels of copy number will make very small changes in expression difficult to detect.
The lower detection limit of this QRT-PCR technique is approximately 100 copies/g total RNA for CYP11B1 and CYP11B2, as determined using homologous standards. The lowest mRNA level consistently detected was in the hippocampus of rats on normal diets, where the CYP11B2 copy number was 540 copies/g total RNA.
Data analysis mRNA expression rates and plasma hormone concentration data were analyzed by the Mann-Whitney U test. For all analyses, P Ͻ 0.05 was required for statistical significance. Data are expressed as the mean Ϯ se.
Results
Effects on plasma renin and corticosteroids
Plasma corticosteroid concentrations and PRA are shown in Table 3 . PRA was significantly higher in the low-sodium diet group and significantly lower in the high-sodium diet group than in the normal diet group. This confirmed that low, normal, and high sodium status had been achieved in the animals. This distinction was not so clear in the plasma aldosterone levels due to the high variability in concentration between these small groups. This may have been due to inadequately controlled acute stress at death, particularly in the high-sodium group where plasma aldosterone was not significantly lower than in the normal group. Plasma aldosterone concentration in the low-sodium group was higher than that in the normal diet group, consistent with the PRA, although this did not quite reach statistical significance (P ϭ 0.07). Nevertheless, these results strongly suggest that sodium diet manipulation, especially low-sodium diet, successfully altered aldosterone synthesis. There was no significant difference between the plasma corticosterone concentrations of the three groups, although the variability within the groups was high. AngII treatment significantly raised plasma aldosterone concentration compared with the vehicle group (P Ͻ 0.05), and PRA was suppressed at this rate of infusion (P Ͻ 0.05). Infusion stimulated aldosterone synthesis, but the effect was less marked than with sodium depletion. Plasma corticosterone concentration was unaltered by infusion.
Quantitative differences in CYP11B1 and B2 expression rates
In the adrenal glands of control animals (i.e. those in the normal sodium intake and vehicle infusion groups), CYP11B1 mRNA levels were 100-to 1000-fold higher than CYP11B2 mRNA. CYP11B1 expression was also consistently higher in all parts of the brain studied. Brain stem and hypothalamus had the highest CYP11B2 transcript levels of the brain regions studied. Cerebral cortex had the lowest CYP11B2 mRNA level, apart from hippocampus, but its CYP11B1 expression was up to 10-fold greater than any other brain region. (For example, control CYP11B1 levels were 1.9 ϫ 10 7 Ϯ 0.4 ϫ 10 7 copies/g RNA in cerebral cortex, 2.1 ϫ 
Effects of sodium intake on gene expression
Expression of both CYP11B1 and CYP11B2 was detected in adrenal glands, hippocampus, cerebellum, hypothalamus, brainstem, and cerebral cortex. Electrophoresis of the RT-PCR products on agarose gels demonstrated that no nonspecific products capable of causing erroneous results were generated in the course of the reaction (Fig. 2) . Representative amplification curves are shown in Fig. 3 .
Low-sodium diet significantly increased CYP11B2 expression in the adrenal gland from 1.0 ϫ 10 5 Ϯ 0.6 ϫ 10 5 to 57 ϫ 10 5 Ϯ 22 ϫ 10 5 copies/g RNA, whereas high-sodium intake decreased CYP11B2 expression to 0.19 ϫ 10 5 Ϯ 0.1 ϫ 10 5 copies/g RNA. Low-sodium intake also increased CYP11B2 mRNA expression in the hippocampus from 5.4 ϫ 10 2 Ϯ 0.8 ϫ 10 2 (normal diet) to 74 ϫ 10 2 Ϯ 31 ϫ 10 2 copies/g RNA (P Ͻ 0.05), and in the cerebellum from 1.9 ϫ 10 3 Ϯ 0.7 ϫ 10 3 to 9.9 ϫ 10 3 Ϯ 3.0 ϫ 10 3 copies/g RNA (P Ͻ 0.01) (Fig. 4) . Low-sodium diet had no significant effect on CYP11B2 expression in the brainstem or hypothalamus. High-sodium diet did not significantly decrease CYP11B2 expression in brain tissues. Sodium intake did not affect CYP11B1 expression in the adrenal gland or brain tissues (Fig. 5) .
Effects of AngII infusion on gene expression
AngII infusion significantly increased CYP11B2 expression in the adrenal gland from 2.7 ϫ 10 6 Ϯ 0.9 ϫ 10 6 in control animals to 17 ϫ 10 6 Ϯ 7.0 ϫ 10 6 copies/g RNA (P Ͻ 0.05). CYP11B2 expression in the hippocampus, cerebellum, hypothalamus, brainstem, and cerebral cortex remained unchanged (Fig. 6) . AngII infusion had no significant effect on CYP11B1 expression in any of these tissues (Fig. 7) . 
Discussion
Real-time RT-PCR methodology
For this study, we developed a system for the quantitative detection of CYP11B1 and CYP11B2 mRNA in total RNA samples. Because of their homology and their extremely low levels of expression in certain extraadrenal tissues, it is imperative that any method be highly specific and sensitive. Our method improves on previous QRT-PCR protocols targeted at these particular genes (5-7, 23, 24) in several respects. Firstly, it employs a homologous RNA standard that is identical to the target sequence. Secondly, the target and standard use identical oligonucleotide primers and probes for amplification and detection. Therefore, the efficiencies of reverse transcription and of amplification for the target and the standard must be identical. By using known quantities of standard, our results can be expressed in absolute terms as the number of transcripts in a given RNA sample. Previous quantitative methods measure products relative to a standard gene, such as ␤-actin, or relative to adrenal CYP11B1 or CYP11B2 mRNA levels. Expressing transcript levels in terms of copy number gives a better index of the level of local expression. The homologous RNA standard, in combination with the sensitivity of the fluorescent LightCycler detection apparatus and hybridization probes, permits the reliable, reproducible, and specific detection of even the very low levels of CYP11B1 and CYP11B2 mRNA present in the CNS.
Expression and regulation of CYP11B1 and CYP11B2 in adrenal tissue
Using this method, the responses of adrenal CYP11B2 mRNA expression to changes in dietary sodium or AngII were as expected from previous published studies of their effects on steroid levels. Decreasing sodium intake caused the levels of adrenal CYP11B2 copy number to increase 57-fold, whereas increased sodium reduced it to a fifth of its basal level (the overall increase in expression from highsodium diet to low-sodium diet was 300-fold). CYP11B1 mRNA levels did not respond significantly to these stimuli.
When comparing control animals from the two studies, it is apparent that adrenal CYP11B2 levels are approximately an order higher in vehicle animals ( Fig. 6 ) than normal sodium diet animals (Fig. 4) . However, both of these levels can be considered compatible with the normal range because plasma aldosterone concentration extends across one order of magnitude. Also, the composition of the chow fed to the two groups of control animals was not identical, and this may have contributed to the adrenal CYP11B2 differences.
Basal expression of CYP11B1 and CYP11B2 in brain tissue
As in previous studies, the levels of CYP11B1 and CYP11B2 transcripts detected in the brain were consistently much lower than those in the adrenal cortex (8, 23, 25) . In animals on normal sodium intake, mRNA copy number was 10 -1000 times lower in the brain than in the adrenal gland, depending on the brain region. Although this could be caused by consistently low levels of transcription across the whole brain region, we suggest that this reflects high expression in a very few cells within that region. Our previous immunohistochemical studies showed that aldosterone synthase and 11␤-hydroxylase were localized to particular cells within regions of the brain. For example, the Purkinje cells of the cerebellum express relatively high levels of aldosterone synthase and 11␤-hydroxylase, but account for a very small fraction of the total cerebellar mass (9) . With this pattern of expression, extraadrenal hormones may act in a paracrine or an autocrine manner on the abundant GR and MR within the brain.
Our QRT-PCR results also demonstrate that expression and regulation of these genes across the brain are not uniform. The fact that copy number varies from region to region reflects the varying proportion of cells that express the CYP11B2 gene in each area, as well as the degree of expression within the individual cells. CYP11B2 transcript levels were particularly variable, covering a 60-fold range from 3.3 ϫ 10 4 copies/g in brainstem to 5.4 ϫ 10 2 copies/g in hippocampus. CYP11B1 levels were higher, but they varied less between regions than those of CYP11B2.
As in previous studies, these results also suggest that CYP11B1 and CYP11B2 expression colocalize within the CNS, something that does not occur in the adrenal cortex due to its strict zonation. This colocalization raises some impor- tant questions. Because aldosterone synthase and 11␤-hydroxylase both use DOC as substrate, do they compete for substrate in tissues where they colocalize? What are their relative affinities for DOC? Can products of 11␤-hydroxylase be used by aldosterone synthase?
Another consideration involves receptor occupancy. Corticosterone binds not only to the GR but also to the MR. In aldosterone-selective tissues, such as the distal nephron, binding of corticosterone by MR is prevented by the enzyme 11␤-hydroxysteroid dehydrogenase type 2 (11␤-HSD2), which inactivates corticosterone. However, the adult brain is, for the most part, nonselective, with high 11␤-HSD2 expression detectable in rat CNS only in the subcommissural organ and nucleus tractus solitarius (26) , important sites of cardiovascular control. In the other CYP11B2-expressing CNS regions, aldosterone has no such priority and, because CYP11B1 expression is consistently higher in any given brain region, locally produced aldosterone may not achieve significant access to the MR. In such cases, there would be little point in regulating CYP11B2 expression unless 11␤-HSD2 was also expressed. It may be, therefore, that it is corticosterone and not aldosterone that is of importance in the majority of the adult rat brain. The 11␤-HSD1 enzyme, on the other hand, favors the production of corticosterone. Its presence is widespread throughout the brain and would, in effect, amplify the effects of local corticosterone production. Although the biological implications of this remain unexplored, knockouts of the local glucocorticoid amplifying enzyme, 11␤-HSD1, show the clear effects of local glucocorticoid regeneration in the CNS upon the hypothalamicpituitary-adrenal axis (27) and hippocampal cognitive function (28), so local amplification by CYP11B1 may provide an effective extra boost to CNS glucocorticoid action when required.
Regulation of CYP11B1 and CYP11B2 in brain tissue
Brain CYP11B1 expression, like that in the adrenal cortex, did not respond to AngII or alterations in dietary sodium.
Restriction of dietary sodium did significantly increase CYP11B2 transcription within the cerebellum and the hippocampus, although the response was less pronounced than in the adrenal gland (a 57-fold increase in the adrenal gland, compared with a 14-fold increase in the hippocampus and a 5-fold increase in cerebellum). This difference between the tissues may partly be due to the activation of the RAS in the adrenal gland. Dietary sodium restriction is known to increase the adrenal concentration of AngII, and this correlates with raised plasma aldosterone levels (29) . The increase in adrenal CYP11B2 mRNA during low-sodium treatment or AngII infusion is partly due to the hypertrophy and hyperplasia of the zona glomerulosa. It is highly unlikely that the brain could react in the same way, and therefore its increase in expression is limited to existing cells. No changes were observed in the hypothalamus or the brainstem, suggesting either that CYP11B2 expression is not subject to stimulation here, that any change was too small to detect, or that it is regulated differently to the cerebellum and the hippocampus.
The effects of AngII on CYP11B2 expression differ in two respects from those of a low-sodium diet. Firstly, the degree of adrenal stimulation with AngII is less than that with lowsodium diet, despite similar increments in plasma aldosterone. Secondly, there are no significant effects of AngII on patterns of CYP11B2 expression in any region of the brain. Differences in adrenal responsiveness might indicate that, in addition to activation of the RAS, other factors such as dopamine, serotonin, atrial natriuretic peptide, and plasma potassium are involved in adaptation to low-sodium diet. This is exemplified by a study comparing the antiproliferative effects of losartan, an angII type 1 (AT1) receptor antagonist; adrenal hyperplasia induced by AngII was prevented, but a similar response to low-sodium diet was unaffected (30) .
Differences in responsiveness in the brain may reflect the fact that low-sodium diet activates the endogenous RAS, whereas AngII suppresses activity. Thus, increases in plasma AngII due to exogenous peptide infusion may be offset by decreased endogenous AngII synthesis. This argument is not dependent on whether AngII crosses the blood-brain barrier because there is clear evidence of an autonomous brain RAS. It is quite possible, for example, that peripheral infusions of pressor doses of AngII could inhibit the brain RAS via effects on blood pressure, whereas a low-sodium diet, which tends to lower blood pressure, might have the opposite effect. It is clearly important for future studies to investigate whether intracerebroventricular infusion of angiotensins or of inhibitors of the RAS can alter brain CYP11B2 mRNA expression independent of changes in the adrenal gland.
We have demonstrated that local expression of CYP11B2 in the CNS can be regulated by manipulation of sodium intake. The mechanism of this regulation is, as yet, unknown. To study this and to investigate whether differences in local expression might contribute to cardiovascular and other diseases will require methods of not only high precision and accuracy but also, because mRNA copy numbers are very low, great sensitivity. This method, we think, has such potential.
